e-learning
resources
Vienna 2003
Sunday 28.09.2003
Mechanisms of epithelial cell activation I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
SP-A and CC-16 expression in COPD patient: correlation with stage of severity and possible pathogenetic role
Z. Alberto, G. Laura, G. Cinzia, R. Annamaria, B. Fulvio, C. G. Walter (Genoa, Italy)
Source:
Annual Congress 2003 - Mechanisms of epithelial cell activation I
Session:
Mechanisms of epithelial cell activation I
Session type:
Thematic Poster Session
Number:
581
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Alberto, G. Laura, G. Cinzia, R. Annamaria, B. Fulvio, C. G. Walter (Genoa, Italy). SP-A and CC-16 expression in COPD patient: correlation with stage of severity and possible pathogenetic role. Eur Respir J 2003; 22: Suppl. 45, 581
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012
Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007
Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma
Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019
Year: 2020
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005
Serum biomarkers in SSc-ILD: association with presence, severity and prognosis
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
The use of FENO in COPD: the relationship to pulmonary function tests and its importance in differential diagnosis.
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory
Source: Annual Congress 2013 –COPD treatment
Year: 2013
The relationship of IL-4 cytokine gene polymorphisms, HRCT and histopathological score in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
The role of serum IL6 in stable COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009
Modified GAP index by including serum KL-6 to assess risk of disease progression in patients with interstitial lung diseases (ILD): preliminary results from the VAMOS study.
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021
The involvement of thrombospondin-1 in COPD pathogenesis through IL-8 production
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Is there any correlation between blood neutrophil inflammatory biochemical markers and lung function impairment in COPD patients?
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
IL8 as a marker of severity of disease progression in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2007; 30: Suppl. 51, 373s
Year: 2007
Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression?
Source: Eur Respir J , 49 (2) 1602345; DOI: 10.1183/13993003.02345-2016
Year: 2017
Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression?
Source: Eur Respir J , 49 (2) 1602524; DOI: 10.1183/13993003.02524-2016
Year: 2017
The prognostic role of the bronchiectasis in patients with COPD
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
The relationship between the serum YKL-40 level and severity of asthma
Source: Annual Congress 2012 - Asthma management
Year: 2012
IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept